Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > Boom, boom, shooting doubles here on the board, just
View:
Post by subaru1i on Sep 24, 2023 6:00pm

Boom, boom, shooting doubles here on the board, just

puffs of smoke.  Ya, Pfizer is the global pharmaceutical partner of Medipharm Labs.   Laid out, easy as A, B, and now you all C the Truth π.   

Well unless of course Pfizer spent $6.7 billion USD on Arena but decides not to buy the cannabinoid pharmaceutical API's from LABS but in reality....MEDIPHARM LABS IS ONLY FDA APPROVED CANNABINOID PHARMACEUTICAL GRADE MOLECULE SUPPLIER THAT PFIZER CAN BUY FROM...and....LABS identified that in 2020 with comments regarding scientific research supporting it and 2 years later...Pfizer nails Arena for new cannabinoid bowel disease drug.  

And to conclude without a single word

$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
Comment by Bronson123 on Sep 24, 2023 6:02pm
https://www.newsfilecorp.com/release/113526/VIVO-CannabisTM-Adds-Assuage-Suppositories-to-Online-Medical-Marketplace
Comment by Starkicker on Sep 25, 2023 9:55am
We should get some kind of indication in the Q3 earnings report in November. It would be a good sign if they bump it up to October as they usually take the full 45 days to report.
Comment by subaru1 on Sep 25, 2023 1:22pm
If they could give us and advice in october that would be nice but i dought it, we will have to wait mid november which is still a long wait......We are loosing traction so a good news would be welcome actually.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities